Previous research has reported that BAG3 is associated with adverse prognoses in a variety of tumors, such as pancreatic cancer [50], Colon Cancer [51], endometrioid endometrial adenocarcinoma [52], and glioblastoma [53]. Here, BAG3 is linked to glioblastoma.